Number of the records: 1  

Neratinib v liečbe HER2+ karcinómu prsníka - profil lieku

  1. SYS0166608
    LBL
      
    00000naa^^22^^^^^^^^450
    005
      
    20200820092352.2
    100
      
    $a 20200727d2020 m y0sloy0103 ba
    101
    0-
    $a slo $d eng $d slo
    102
      
    $a SK
    200
    1-
    $a Neratinib v liečbe HER2+ karcinómu prsníka - profil lieku $d Neratinib in treatment of HER2+ breast cancer - drug profile $f Radovan Barila $z eng
    215
      
    $c ilustr., obr., tab.
    320
      
    $a Bibliogr. odkazy
    320
      
    $a Res. angl., slov.
    463
    -1
    $1 001 sllk_un_cat*0166388 $1 011 $a 1336-8176 $1 200 1 $a Onkológia $v Roč. 15, č. 3 (2020), s. 215-219 $1 210 $a Bratislava $c SOLEN $d 2020 $1 215 $a s. 157-230
    510
    1-
    $a Neratinib in treatment of HER2+ breast cancer - drug profile $z eng
    606
    1-
    $3 sllk_un_auth*d001943 $a nádory prsníka $2 mesh
    610
    2-
    $a neratinib
    610
    2-
    $a karcinóm prsníka primárny HER2 pozitívny
    610
    2-
    $a štúdia ExteNet
    700
    -1
    $3 sllk_un_auth*0018607 $a Barila $b Radovan $p Svet zdravia, NsP Štefana Kukuru, Michalovce $4 070
    801
    -0
    $a SK $b BA006 $c 20200727 $g AACR2
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.